Media ReleasesRadiopharm Theranostics

View All Radiopharm Theranostics News


Radiopharm Theranostics - Letter to shareholders


Dear Fellow RAD Shareholders,

We are living in turbulent times on the ASX, as evidenced by the selling pressure our company has experienced since the day of our listing, only two weeks ago.

Like ourselves, you are all asking why? What has fundamentally changed for RAD since the strongly supported IPO offer?

Well, nothing has changed at RAD, indeed we are more enthusiastic than ever about the company’s prospects. We are confident that as we deliver on our strategy the share price will look after itself. 

For more information, download the attached PDF.

Download this document

Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?